Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway

Breast Cancer Research

Volumn 12, Issue 6, 2010, Pages

  Mao, Lulu ^a   Yuan, Lin ^a   Slakey, Lauren M ^a   Jones, Frank E ^b   Burow, Matthew E ^a   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE A; GELATINASE B; LUZINDOLE; MATRIGEL; MELATONIN; MELATONIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STROMAL CELL DERIVED FACTOR 1; MATRIX METALLOPROTEINASE; TRYPTAMINE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL PROLIFERATION; CLONING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; MATRIGEL INVASION CHAMBER ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MELATONIN; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, MELATONIN, MT1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRYPTAMINES;

EID: 79960425073     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2794     Document Type: Article

References (46)

1. Barni S, Lissoni P, Crispino S, Cattaneo G, Rovelli F, Fumagalli G, Tancini G. Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratio. Int J Biol Markers 1988, 3:82-86.
2. Lissoni P, Bastone A, Sala R, Mauri R, Rovelli F, Viviani S, Bajetta E, Esposti D, Esposti G, di Bella L, Fraschini F. The clinical significance of melatonin serum determination in oncological patients and its correlation with GH and PRL blood levels. Eur J Cancer Clin Oncol 1987, 23:949-957. 10.1016/0277-5379(87)90340-3, 3666000.
3. Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998, 58:4383-4390.
4. Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, Semenchenko AV, Yashin AI. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 2003, 103:300-305. 10.1002/ijc.10827, 12471612.
5. Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, Mancini R, Franceschi C. The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett 2001, 22:441-447.
6. Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo an in vitro. J Pineal Res 2003, 35:204-211. 10.1034/j.1600-079X.2003.00077.x, 12932205.
7. Bracke ME, Van Larebeke NA, Vyncke BM, Mareel MM. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 1991, 63:867-872. 1972531, 1648947.
8. Correc P, Fondaneche M-C, Bracke M, Burtin P. The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer 1990, 46:745-750. 10.1002/ijc.2910460432, 2170280.
9. Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res 2003, 284:99-110. 10.1016/S0014-4827(02)00099-X, 12648469.
10. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988, 48:1238-1243.
11. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol Endocrinol 2001, 15:1344-1359. 10.1210/me.15.8.1344, 11463858.
12. Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP. ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer 2000, 82:666-674. 10.1054/bjoc.1999.0979, 2363331, 10682681.
13. Tan M, Yao J, Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res 1997, 57:1199-1205.
14. Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2002, 2:451-461. 10.1016/S1535-6108(02)00212-X, 12498714.
15. Ke Z, Lin H, Fan Z, Cai TQ, Kaplan RA, Ma C, Bower KA, Shi X, Luo J. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int J Cancer 2006, 119:8-16. 10.1002/ijc.21769, 16450376.
16. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
17. Liang ZX, Yoon YH, Votaw H, Goodman MM, Williams L, Shim H. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 2005, 65:967-971.
18. Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 2003, 63:4801-4804.
19. Bendall LJ, Baraz R, Juarez J, She W, Bradstock KF. Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res 2005, 65:3290-3298.
20. Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, Arthur JS, Case LM, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal 2006, 18:1897-1905. 10.1016/j.cellsig.2006.02.006, 16574378.
21. Robledo MM, Bartolome RA, Longo N, Rodríguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sánchez-Mateos P, Teixidó J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001, 276:45098-45105. 10.1074/jbc.M106912200, 11571298.
22. Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cell. J Biol Chem 2002, 277:48379-48385. 10.1074/jbc.M209542200, 12377770.
23. Kim MS, Lee EJ, Kim HR, Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003, 63:5454-5461.
24. Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, Paradiso A, Casavola V, Zaccolo M, Reshkin SJ. Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell 2005, 16:3117-3127. 10.1091/mbc.E04-10-0945, 1165397, 15843433.
25. Shin I, Kim S, Song H, Kim HR, Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 2005, 280:14675-14683. 10.1074/jbc.M411625200, 15677464.
26. Delghandi MP, Johannessen M, Moens U. The cAMP signaling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal 2005, 17:1343-1351. 10.1016/j.cellsig.2005.02.003, 16125054.
27. Suzuki A, Palmer G, Bonjour JP, Caverzasio J. Regulation of alkaline phoaphatase activity of p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology 1999, 140:3177-3182. 10.1210/en.140.7.3177, 10385412.
28. Husain S, Abdel-Latif AA. Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholiase A2 in cat iris sphincter smooth muscle cells. Biochem J 1999, 342:87-96. 10.1042/0264-6021:3420087, 1220440, 10432304.
29. Komatsu J, Yamano S, Kuwahara A, Tokumura A, Irahara M. The signaling pathways linking to lysophosphatidic aid-promoted meiotic maturation in mice. Life Sci 2006, 79:506-511. 10.1016/j.lfs.2006.01.028, 16492384.
30. Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP. Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or Gbeta gamma in a adult mouse cardiomyocytes. J Biol Chem 2000, 275:40635-40640. 10.1074/jbc.M006325200, 11018034.
31. Kiefer TL, Yuan L, Ram PT, Hill SM. Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2002, 71:37-45. 10.1023/A:1013301408464, 11859872.
32. Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, Hill SM. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett 2002, 179:141-150. 10.1016/S0304-3835(01)00873-4, 11888668.
33. Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167. 10.1038/sj.onc.1206910, 14712221.
34. Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM. MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002, 192:147-156. 10.1016/S0303-7207(02)00029-1, 12088876.
35. Collins A, Yuan L, Kiefer TL, Cheng Q, Lai L, Hill SM. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett 2003, 189:49-57. 10.1016/S0304-3835(02)00502-5, 12445677.
36. Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007, 1773:1358-1375.
37. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003, 2:29. 10.1186/1476-4598-2-29, 194255, 12971829.
38. Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 2002, 21:2309-2319. 10.1038/sj.onc.1205297, 11948414.
39. Swarnakar S, Mishra A, Ganguly K, Sharma AV. Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007, 43:56-64. 10.1111/j.1600-079X.2007.00443.x, 17614836.
40. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 2008, 44:439-449. 10.1111/j.1600-079X.2007.00547.x, 18298469.
41. Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs (Protein Profile) 2000, New York, NY: Oxford University Press.
42. Chan AS, Lai FP, Lo RK, Voyno-Yasenetskaya TA, Stanbridge EJ, Wong YH. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal 2002, 14:249-257. 10.1016/S0898-6568(01)00240-6, 11812653.
43. Kilic U, Kilic E, Reiter RJ, Bassetti CL, Hermann DM. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemic in mice. J Pineal Res 2005, 38:67-71. 10.1111/j.1600-079X.2004.00178.x, 15617539.
44. Radio NM, Doctor JS, Witt-Enderby PA. Melatonin enhances alkaline phoshoatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 2006, 40:332-342. 10.1111/j.1600-079X.2006.00318.x, 16635021.
45. Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G. p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem 2010, 285:15149-15158. 10.1074/jbc.M110.105429, 20231272.
46. Teplitzky SR, Kiefer TL, Cheng Q, Dwivedi PD, Moroz K, Myers L, Anderson MB, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM. Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 2001, 168:155-163. 10.1016/S0304-3835(01)00548-1, 11403920.